Navaja, Baby Girl .

HRN: 28-31-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2025
AMPICILLIN 500MG (VIAL)
12/30/2025
01/06/2026
IV
145mg
Q12
PSNB (PROM X 15hrs)
Checking Initial Appropriateness 
12/30/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
12/30/2025
01/06/2026
IV
15mg
Q24
PSNB (PROM X 15hrs)
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: